Neo Ivy Capital Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
17,256
+12,804
| +288% | +$1.29M | 0.55% | 64 |
|
|
2025
Q1 | $340K | Buy |
+4,452
| New | +$340K | 0.11% | 210 |
|
|
2024
Q3 | – | Sell |
-18,436
| Closed | -$1.24M | – | 329 |
|
|
2024
Q2 | $1.24M | Buy |
+18,436
| New | +$1.24M | 0.24% | 133 |
|
|
2022
Q4 | $116K | Sell |
5,790
-2,841
| -33% | -$56.9K | 0.08% | 255 |
|
|
2022
Q3 | $186K | Buy |
8,631
+6,810
| +374% | +$147K | 0.49% | 68 |
|
|
2022
Q2 | $35K | Sell |
1,821
-2,205
| -55% | -$42.4K | 0.09% | 266 |
|
|
2022
Q1 | $94K | Buy |
4,026
+3,349
| +495% | +$78.2K | 0.08% | 309 |
|
|
2021
Q4 | $18K | Buy |
677
+221
| +48% | +$5.88K | 0.03% | 364 |
|
|
2021
Q3 | $13K | Sell |
456
-1,211
| -73% | -$34.5K | 0.01% | 411 |
|
|
2021
Q2 | $47K | Buy |
+1,667
| New | +$47K | 0.05% | 326 |
|
|
2020
Q3 | – | Sell |
-456
| Closed | -$13K | – | 534 |
|
|
2020
Q2 | $13K | Buy |
+456
| New | +$13K | 0.01% | 411 |
|